names of glp 1 agonists GLP-1 Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care GLP-1’s (incretin mimetics), This type

The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes

This included heart attack and stroke, by 20% in adults with obesity or overweight who already had cardiovascular disease, even without diabetes (Reference)

The secondary endpoints were the percentage change in body weight from baseline to 48 weeks and the presence of weight reduction in 5%, 10%, and 15%

But Pfizer appeared to be confident in the once-daily form of danuglipron back in July, when it said it would start conducting studies in the second half of the year to evaluate multiple doses of the pill

doi: 10.1080/03007995.2018.1465903